AU2003201554A8 - Quantitative ranking of transient ligand binding to target biomolecules - Google Patents

Quantitative ranking of transient ligand binding to target biomolecules

Info

Publication number
AU2003201554A8
AU2003201554A8 AU2003201554A AU2003201554A AU2003201554A8 AU 2003201554 A8 AU2003201554 A8 AU 2003201554A8 AU 2003201554 A AU2003201554 A AU 2003201554A AU 2003201554 A AU2003201554 A AU 2003201554A AU 2003201554 A8 AU2003201554 A8 AU 2003201554A8
Authority
AU
Australia
Prior art keywords
ligand binding
target biomolecules
quantitative ranking
transient
transient ligand
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003201554A
Other versions
AU2003201554A1 (en
Inventor
Feng Ni
Ping Xu
Michael J Osborne
Dmitri Tolkatchev
Anatol Koutychenko
Zhengding Su
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Research Council of Canada
Original Assignee
National Research Council of Canada
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National Research Council of Canada filed Critical National Research Council of Canada
Publication of AU2003201554A8 publication Critical patent/AU2003201554A8/en
Publication of AU2003201554A1 publication Critical patent/AU2003201554A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N24/00—Investigating or analyzing materials by the use of nuclear magnetic resonance, electron paramagnetic resonance or other spin effects
    • G01N24/08—Investigating or analyzing materials by the use of nuclear magnetic resonance, electron paramagnetic resonance or other spin effects by using nuclear magnetic resonance
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/46—NMR spectroscopy
    • G01R33/4625—Processing of acquired signals, e.g. elimination of phase errors, baseline fitting, chemometric analysis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/46—NMR spectroscopy
    • G01R33/465—NMR spectroscopy applied to biological material, e.g. in vitro testing
AU2003201554A 2002-01-11 2003-01-10 Quantitative ranking of transient ligand binding to target biomolecules Abandoned AU2003201554A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34689402P 2002-01-11 2002-01-11
US60/346,894 2002-01-11
PCT/CA2003/000014 WO2003057258A2 (en) 2002-01-11 2003-01-10 Quantitative ranking of transient ligand binding to target biomolecules

Publications (2)

Publication Number Publication Date
AU2003201554A8 true AU2003201554A8 (en) 2003-07-24
AU2003201554A1 AU2003201554A1 (en) 2003-07-24

Family

ID=23361467

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003201554A Abandoned AU2003201554A1 (en) 2002-01-11 2003-01-10 Quantitative ranking of transient ligand binding to target biomolecules

Country Status (5)

Country Link
US (1) US20050287527A1 (en)
EP (1) EP1463952A2 (en)
AU (1) AU2003201554A1 (en)
CA (1) CA2472193A1 (en)
WO (1) WO2003057258A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO20025738D0 (en) 2002-11-29 2002-11-29 Amersham Health As Method
WO2004076484A1 (en) * 2003-02-27 2004-09-10 National Research Council Of Canada Peptide inhibitors of thrombin as potent anticoagulants
WO2006000081A1 (en) * 2004-06-23 2006-01-05 National Research Council Of Canada Polypeptide ligands containing linkers
US9678185B2 (en) 2013-03-15 2017-06-13 Pepsico, Inc. Method and apparatus for measuring physico-chemical properties using a nuclear magnetic resonance spectrometer
US10267754B2 (en) 2013-04-12 2019-04-23 University Of Maryland, Baltimore Assessing biopharmaceutical aggregation using magnetic resonance relaxometry
EP3547914A4 (en) 2016-12-02 2020-11-11 University Of Maryland, Baltimore Solvent nuclear magnetic resonance for noninvasive inspection of particle-containing products
US11543371B2 (en) 2018-10-04 2023-01-03 University Of Maryland, Baltimore In situ, real-time in-line detection of filling errors in pharmaceutical product manufacturing using water proton NMR
US11585770B2 (en) 2018-10-04 2023-02-21 University Of Maryland, Baltimore In situ determination of alum filling evenness and sedimentation in pharmaceutical products using water proton NMR
CN110196260B (en) * 2019-06-14 2021-05-11 中国科学院大连化学物理研究所 High-sensitivity three-dimensional nuclear magnetic resonance spectrum method
CN110161072B (en) * 2019-06-19 2021-05-25 中国科学院大连化学物理研究所 Method for identifying paraffin and cycloparaffin based on three-dimensional nuclear magnetic resonance spectrum
EP4076537A4 (en) 2019-12-20 2024-02-28 Univ Maryland Noninvasive quantitation of full versus empty capsids using water proton nmr
US11914013B2 (en) 2020-08-18 2024-02-27 University Of Maryland, Baltimore Real-time in situ monitoring of suspension sedimentation using water proton NMR
US20230349892A1 (en) * 2022-04-27 2023-11-02 Bio-Rad Laboratories, Inc. High sensitivity immunoassay

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5891643A (en) * 1995-11-14 1999-04-06 Abbott Laboratories Use of nuclear magnetic resonance to design ligands to target biomolecules

Also Published As

Publication number Publication date
WO2003057258A3 (en) 2003-10-16
CA2472193A1 (en) 2003-07-17
WO2003057258A2 (en) 2003-07-17
US20050287527A1 (en) 2005-12-29
AU2003201554A1 (en) 2003-07-24
EP1463952A2 (en) 2004-10-06

Similar Documents

Publication Publication Date Title
IL255015A (en) Monomethylvaline compounds capable of conjugation to ligands
HRP20151102T1 (en) Human monoclonal antibodies to programmed death ligand 1 (pd-l1)
AU2003201554A8 (en) Quantitative ranking of transient ligand binding to target biomolecules
AU2003216341A8 (en) Mhc-peptide complex binding ligands
AU2002365420A1 (en) Ligands to enhance cellular uptake of biomolecules
ZA200606733B (en) Novel canola protein isolat
IL218524A0 (en) Compositions and methods relating to novel compounds and targets thereof
IL172906A0 (en) Specific binding agents to hepatocyte growth factor
IL188671A0 (en) Il-6 binding proteins
AT503097A3 (en) SNOWBOARD BINDING
ZA200505988B (en) Breast cancer resistance protein (BCRP) inhibitor
DK1659880T3 (en) Composition for animal nutrition
AU2003234706A8 (en) Antibodies that specifically bind to tl5
AU2003256299A1 (en) Antibodies that specifically bind to reg iv
AU2003218456A8 (en) Antibodies that specifically bind to gmad
AU2003286645A8 (en) Antibody-mediated induction of tumor cell death
AU2003223218A1 (en) Methods for identifying a molecule that may bind to a target molecule
EP1610808A4 (en) Covalent attachment of ligands to nucleophilic proteins guided by non-covalent binding
EP1688436A4 (en) Composition of antibody capable of specifically binding ccr4
EP1811039A4 (en) Method of efficiently screening protein capable of specific binding to ligand
AU2003201559A8 (en) Multispecific binding molecules
AU2001268944A1 (en) Method for determining the quantity of ligands that are bound to target molecules
AU2002314088A1 (en) Method for determining the binding behaviour of ligands which specifically bind to target molecules
AU2003304087A1 (en) Methods for producing zinc finger proteins that bind to extended dna target sequences
GB0511799D0 (en) Protein binding ligands

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase